Form 4 for EBS Emergent BioSolutions Inc.

Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-03 · accession 0000899243-21-047222 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-12-07	2021-12-03	EBS	El-Hibri Fuad	Dir	J - Other	$0.00	+3.50M	3.02M	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-03	J	A	274,930	$0.00	274,930	I See Footnote	—	—	(F3) Held by the El-Hibri Family Trust, for which the reporting person's wife serves as the Trustee. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the El Hibri Family Trust except to the extent of his pecuniary interest therein.
2	Common	Common Stock	2021-12-03	J	A	206,434	$0.00	206,434	I See Footnote	—	—	(F4) Held by the El-Hibri Decedents Trust, for which the reporting person serves as the Trustee. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the El-Hibri Decendents Trust except to the extent of his pecuniary interest therein.
3	Common	Common Stock	2021-12-03	J	A	3,018,644	$0.00	3,018,644	I See Footnote	—	—	(F2) Held by the Yahia Fuad El-Hibri Revocable Trust, for which the reporting person serves as the Trustee. Comprised of (i) 1,659,099 shares of the Issuer's common stock previously reported as beneficially owned by Intervac and (ii) 1,359,545 shares of the Issuer's common stock previously reported as beneficially owned by BioVac. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the Yahia Fuad El-Hibri Revocable Trust except to the extent of his pecuniary interest therein.